Your browser doesn't support javascript.
loading
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Beijert, Irene J; Hentschel, Anouk E; Bründl, Johannes; Compérat, Eva M; Plass, Karin; Rodríguez, Oscar; Subiela Henríquez, Jose D; Hernández, Virginia; de la Peña, Enrique; Alemany, Isabel; Turturica, Diana; Pisano, Francesca; Soria, Francesco; Capoun, Otakar; Bauerová, Lenka; Pesl, Michael; Bruins, H Maxim; Runneboom, Willemien; Herdegen, Sonja; Breyer, Johannes; Brisuda, Antonin; Calatrava, Ana; Rubio-Briones, José; Seles, Maximilian; Mannweiler, Sebastian; Bosschieter, Judith; Kusuma, Venkata R M; Ashabere, David; Huebner, Nicolai; Cotte, Juliette; Mertens, Laura S; Claps, Francesco; Masson-Lecomte, Alexandra; Liedberg, Fredrik; Cohen, Daniel; Lunelli, Luca; Cussenot, Olivier; El Sheikh, Soha; Volanis, Dimitrios; Côté, Jean-François; Rouprêt, Morgan; Haitel, Andrea; Shariat, Shahrokh F; Mostafid, A Hugh; Nieuwenhuijzen, Jakko A; Zigeuner, Richard; Dominguez-Escrig, Jose L; Hacek, Jaromir; Zlotta, Alexandre R; Burger, Maximilian.
Afiliación
  • Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
  • Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Capoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.
  • Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.
  • Pesl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.
  • Bruins HM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.
  • Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Seles M; Department of Urology, Medical University of Graz, Graz, Austria.
  • Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.
  • Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
  • Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
  • Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
  • Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.
  • Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.
  • Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.
  • Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
  • Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
  • Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
  • El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
  • Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
  • Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.
  • Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.
  • Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
  • Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University
  • Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
  • Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.
  • Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.
  • Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
  • Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.
Eur Urol Oncol ; 6(2): 214-221, 2023 04.
Article en En | MEDLINE | ID: mdl-36670042
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article